234 related articles for article (PubMed ID: 26198328)
1. Role of DNA methylation in renal cell carcinoma.
Shenoy N; Vallumsetla N; Zou Y; Galeas JN; Shrivastava M; Hu C; Susztak K; Verma A
J Hematol Oncol; 2015 Jul; 8():88. PubMed ID: 26198328
[TBL] [Abstract][Full Text] [Related]
2. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
3. Identification of DNA Methylation-Independent Epigenetic Events Underlying Clear Cell Renal Cell Carcinoma.
Becket E; Chopra S; Duymich CE; Lin JJ; You JS; Pandiyan K; Nichols PW; Siegmund KD; Charlet J; Weisenberger DJ; Jones PA; Liang G
Cancer Res; 2016 Apr; 76(7):1954-64. PubMed ID: 26759245
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.
Xu B; Zhang L; Luo C; Qi Y; Cui Y; Ying JM; Zhang Q; Jin J
Int J Mol Sci; 2015 Jan; 16(1):1051-65. PubMed ID: 25569086
[TBL] [Abstract][Full Text] [Related]
5. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B
J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation status defines clinicopathological parameters including survival for patients with clear cell renal cell carcinoma (ccRCC).
Evelönn EA; Degerman S; Köhn L; Landfors M; Ljungberg B; Roos G
Tumour Biol; 2016 Aug; 37(8):10219-28. PubMed ID: 26831665
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
[TBL] [Abstract][Full Text] [Related]
10. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of CRB3 is a prognostic biomarker in clear cell renal cell carcinoma.
Li P; Liu J; Li J; Liu P
Mol Biol Rep; 2019 Aug; 46(4):4377-4383. PubMed ID: 31147860
[TBL] [Abstract][Full Text] [Related]
12. Protocadherin17 Promoter Methylation is a Potential Predictive Biomarker in Clear Cell Renal Cell Carcinoma.
Lin YL; Gui SL; Guo H; Ma JG; Li WP
Med Sci Monit; 2015 Sep; 21():2870-6. PubMed ID: 26404644
[TBL] [Abstract][Full Text] [Related]
13. [Suppression of NR0B2 gene in Clear Cell Renal Cell Carcinoma Is Associated with Hypermethylation of Its Promoter].
Kudryavtseva AV; Nyushko KM; Zaretsky AR; Shagin DA; Sadritdinova AF; Fedorova MS; Savvateeva MV; Guvatova ZG; Pudova EA; Alekseev BY; Dmitriev AA; Snezhkina AV
Mol Biol (Mosk); 2018; 52(3):482-488. PubMed ID: 29989580
[TBL] [Abstract][Full Text] [Related]
14. A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data.
Zhao H; Leppert JT; Peehl DM
PLoS One; 2016; 11(1):e0146505. PubMed ID: 26814892
[TBL] [Abstract][Full Text] [Related]
15. TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.
Gooskens SL; Klasson TD; Gremmels H; Logister I; Pieters R; Perlman EJ; Giles RH; van den Heuvel-Eibrink MM
Mol Oncol; 2018 Feb; 12(2):166-179. PubMed ID: 29080283
[TBL] [Abstract][Full Text] [Related]
16. DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
Fu RJ; He W; Wang XB; Li L; Zhao HB; Liu XY; Pang Z; Chen GQ; Huang L; Zhao KW
Cell Death Dis; 2017 Jul; 8(7):e2952. PubMed ID: 28749461
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro.
Wu A; Wu K; Li M; Bao L; Shen X; Li S; Li J; Yang Z
Mol Med Rep; 2015 Jul; 12(1):1413-20. PubMed ID: 25815441
[TBL] [Abstract][Full Text] [Related]
18. Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis.
Tezval H; Dubrowinskaja N; Peters I; Reese C; Serth K; Atschekzei F; Hennenlotter J; Stenzl A; Kuczyk MA; Serth J
PLoS One; 2016; 11(10):e0163873. PubMed ID: 27695045
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Köllermann J; Miller K; Schrader M
Clin Cancer Res; 2006 Sep; 12(17):5040-6. PubMed ID: 16951219
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer.
Miyakuni K; Nishida J; Koinuma D; Nagae G; Aburatani H; Miyazono K; Ehata S
Mol Oncol; 2022 Feb; 16(3):732-749. PubMed ID: 34133843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
